Faulty proteins may prove significant in identifying new treatments for ovarian cancer
Saturday, January 14, 2012 - 00:30
in Health & Medicine
A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, a new study found.